A Study of Econazole Foam 1% in Athlete's Foot

Status Completed

Clinical Trial Summary

This is a 6-week clinical study (4 weeks of treatment, once per day, plus a 2-week follow-up period) of a topical foam to treat athlete's foot. The active ingredient in the foam -- econazole nitrate 1% -- is the same active pharmaceutical ingredient in a cream that your doctor can currently prescribe to treat athlete's foot. This study will help to understand if the foam works the same as the cream to treat athlete's foot.

Clinical Trial Description

Treating athlete's foot with a cream can leave a greasy, wet feeling on the foot that is uncomfortable to the user and messy on clothing and foot wear. A foam formulation that spreads easily and rubs-in easily that is as effective as the (reference) cream formulation in treating athlete's foot would be a benefit to the user. This study is designed to substantiate a clinical bridge between econazole nitrate foam 1% and econazole nitrate cream 1% based on clinical outcome, safety, and pharmacokinetic data. The study is (foam) vehicle-controlled and is randomized 1 to 1 to 1 (foam:cream:vehicle). ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00768599
Study type	Interventional
Source	AmDerma
Contact
Status	Completed
Phase	Phase 2
Start date	March 2008
Completion date	October 2008

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05493488` - A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis	Phase 2
Completed	`NCT04883593` - A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.	Early Phase 1
Terminated	`NCT02842021` - Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis	Phase 2
Completed	`NCT01712360` - Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis	Phase 4
Completed	`NCT00781664` - Cumulative Irritation Test	Phase 1
Completed	`NCT03676686` - Study With Nåva Foot Cream in Patients With Tinea Pedis Interdigitalis	N/A
Completed	`NCT01519752` - A Therapeutic Equivalence Study of Two Oxiconazole Nitrate Topical Cream Treatments for Patients With Tinea Pedis	Phase 1
Completed	`NCT03320486` - Non-inferiority Trial of Dapaconazole Versus Ketoconazole	Phase 3
Completed	`NCT01580891` - Evaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea Pedis	Phase 1
Completed	`NCT01353976` - Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea Pedis	Phase 3
Completed	`NCT01349998` - Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis	Phase 3
Completed	`NCT04265521` - Study With BioCool Footcare in Subjects With Tinea Pedis Interdigitalis and Heel Cracks, Calluses and/or Dry Feet	N/A
Completed	`NCT02633813` - BE Study of Naftifine HCL	Phase 3
Recruiting	`NCT00856596` - Once a Day Topical Treatment for Athlete's Foot Fungus Inbetween the Toes in Males and Females	Phase 3
Completed	`NCT00869336` - Multicenter Study of the Efficacy and Safety of Luliconazole Cream in Tinea Pedis (Athlete's Foot)	Phase 2
Recruiting	`NCT00233493` - Spread of Dermatophytes Among Families	N/A
Completed	`NCT03897257` - A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis	Phase 2
Completed	`NCT03129321` - Therapeutic Equivalence and Safety of Two Econazole Nitrate Cream, 1% Products in Tinea Pedis	Phase 3
Completed	`NCT02335255` - Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea Pedis	Phase 1
Withdrawn	`NCT02606383` - Non-inferiority Phase III Trial Comparing Dapaconazole Cream 2% With Ketoconazole Cream 2% in Patients With Tinea Pedis	Phase 3